Companies: 10,795·Total market cap: $144.5T

Agenus Inc.

Agenus Inc.

AGENNASDAQHealthcare● Active

$3.14

$-0.09(-2.79%)

Market Cap$130757136

P/E Ratio—

52W High$7.34

52W Low$2.71

Avg Volume828K

Open$3.30

Beta1.57

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Agenus Inc.（AGEN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · AGEN · 截至 Jun 9, 2026

关键指标

EPS (TTM)$1.73Earnings history

PE Ratio (TTM)1.8×PE Ratio deep dive

Revenue (TTM)$123.9MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding29.7MShares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Agenus Inc. 数据

分析师预测$7 · Buy

股息不分红

营收$114.2M+10.37%

盈利EPS $-0.00+99.97%

财务快照

FY 2025Revenue$114.2M▲ +10.37% YoY

202320242025

FY 2025Net Income$115000.00▲ +100.05% YoY

202320242025

FY 2025EPS$-0.00▲ +99.97% YoY

202320242025

TTM:Revenue: $123.9MNet Income: $64.6MEPS: $1.73View income statement →

分析师评级与目标价

Buy11 位分析师

Strong Buy

0

Buy

8

Hold

3

Sell

0

Strong Sell

0

12-Month Price Target

$7.00Low

$3.14Current

$7.33Avg Target上涨空间 133.44%

$8.00High

合计: 11 · 买入占比: 72.7%

根据过去 3 个月内 11 位华尔街分析师，AGEN 共识评级为 Buy，12 个月平均目标价 $7.33 （较现价 $3.14 上涨空间 133.44%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$3.14-2.79%$130.8M #2

Acumen Pharmaceuticals, Inc.

$2.17+0.93%$131.4M #3

Fate Therapeutics, Inc.

$1.91-3.54%$222.6M #4

TuHURA Biosciences, Inc.

$2.05+4.07%$130.2M #5

Inovio Pharmaceuticals, Inc.

$1.09+1.87%$58.4M #6

Opus Genetics, Inc.

$4.03+0.00%$328.0M

股票表现

1D-2.79%

1W-6.55%

1M-17.80%

3M+6.08%

YTD+0.00%

1Y-43.42%

5Y-96.85%

关于 Agenus Inc.

CEOGaro H. Armen

IPO DateFeb 8, 2000

Employees316

CountryUS

Websiteagenusbio.com

Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes …

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Agenus Inc.（AGEN）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 8, 2000 在 NASDAQ 上市。截至最近交易日，AGEN 股价为 $3.14，市值约为 $130.8M。过去12个月累计回报 -43.42%，年初至今回报 +0.00%。

根据 11 位华尔街分析师，Agenus Inc. 股票共识评级为Buy，12个月平均目标价为 $7.33。2025 财年 Agenus Inc. 营收 $114.2M，净利润 $115000.00。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Agenus Inc.（AGEN）股价为 $3.14，在 NASDAQ 上市，52周区间为 $2.71 – $7.34。

AGEN 最新股价AGEN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议